SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Mish's Global Economic Trend Analysis -- Ignore unavailable to you. Want to Upgrade?

To: Little Joe who wrote (98835)6/23/2009 11:21:34 AM
From: bacchus_ii1 Recommendation  Read Replies (1) | Respond to of 116555
 
who would invest in new drugs if that were the case?


Gov. and public. They already found a big part of it. Most of the work done by big Pharma. co. are to protect their market, taking or buying IP that could cure a highly profitable sickness, delaying little improvement just in time for the expiration of an IP in order to prolong profitability ... etc

It's not because a co. can take IP on a new (or even manufactured) illness that they can holdup humanity to give them all the money they ask.

When you own the means to save life or reduce suffering of other, it's a limit where you can not ask more than normal remuneration.



To: Little Joe who wrote (98835)6/23/2009 3:08:09 PM
From: NOW  Respond to of 116555
 
the federal government perhaps, who by the way paid for many of the best


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News